Japan Set To Launch First Trial Of Drug To Kill Cancer Stem Cells
This article was originally published in PharmAsia News
Executive Summary
The first clinical study in Japan of a treatment aimed at killing cancer stem cells is expected to begin in early April to test use of sulfasalazine, approved in the U.S. for treating ulcerative colitis.